HOME > TOP STORIES
TOP STORIES
-
REGULATORY Govt Mulls New AMED Organ to Lead Strategic Funding for Vaccine Development
May 26, 2021
-
BUSINESS Sawai, Towa Post Domestic Sales Growth in FY2020, but Nichi-Iko Falters on GMP Violations: Jiho Tally
May 26, 2021
-
REGULATORY Japan Eyes Pfizer Vaccine Use in Younger People, Longer Refrigerator Storage
May 26, 2021
-
ORGANIZATION JPMA Positive on Use of Clinical Research Data in Submissions, but Wary of Funding Database
May 26, 2021
-
BUSINESS Flawed Stability Tests Found for 31 Choseido-Manufactured Products, Recalls Hit 15
May 25, 2021
-
REGULATORY MHLW Panel Backs Japan’s 1st Oncolytic Virus for Conditional Approval
May 25, 2021
-
BUSINESS Novartis Aims to Become Leader in Japan MS Market with Kesimpta Rollout
May 25, 2021
-
ORGANIZATION Ken Suzuki Likely to Come Back as JPWA Chief after 2 Years
May 25, 2021
-
BUSINESS Japan Ethical Drug Market Contracts 1% in Jan.-Mar.; Keytruda Top-Selling Drug for 8th Quarter Running: IQVIA
May 25, 2021
-
BUSINESS Janssen Seeks Japan Approval for COVID-19 Vaccine
May 24, 2021
-
REGULATORY MOF Panel’s Proposal Urges More Stringent Drug Cost Control, Revisiting of Semi-Automatic Listing
May 24, 2021
-
REGULATORY Biz Improvement Order Issued to 3 Codevelopers over Kobayashi Kako’s Fudged Data
May 24, 2021
-
REGULATORY PMDA Review Report: Flexible Discussions Needed for Eligibility of AstraZeneca Vaccine
May 24, 2021
-
ORGANIZATION JPMA Will Work towards Price Maintenance for On-Patent Medicines: New President
May 24, 2021
-
REGULATORY Japan Approves Moderna and AstraZeneca COVID-19 Vaccines
May 21, 2021
-
REGULATORY AstraZeneca, Moderna COVID-19 Vaccines in Line for Japan Approval on May 21
May 21, 2021
-
BUSINESS AbbVie Looks to Continue Double-Digit Annual Growth in New 5-Year Biz Plan
May 21, 2021
-
BUSINESS Janssen’s Darzquro, Chugai’s Polivy, JCR’s Izcargo Now Available in Japan
May 20, 2021
-
BUSINESS 5-Camp Battle Heating Up in HIF-PH Market; Evrenzo, Duvroq Neck-and-Neck for Top Spot
May 19, 2021
-
REGULATORY Pharma to Govt: Maintain Prices of Patented Drugs, It’s the Global Standard
May 18, 2021
ページ
On paper, things should be looking up for Japan’s pharmaceutical wholesalers. Industry expectations are mounting that the average gap between NHI and market prices will narrow further in FY2026 from the previous year’s record low of 4.8%.A shrinking gap should…
Tariffs have been a defining feature of US trade policy under President Donald Trump’s second administration. Since Trump unveiled his “reciprocal” tariff policy in April 2025, the landscape has shifted repeatedly.In February 2026, the US Supreme Court invalidated tariffs imposed…
